Mereo BioPharma Group PLC ADR Cash Flow Reinvestment Rate
Latest as of September 2023:
0.00x
Mereo BioPharma Group PLC ADR cash flow reinvestment rate. Mereo BioPharma Group PLC ADR (MREO) has a Cash Flow Reinvestment Rate of 0.00x as of September 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $2.66 Million. Explore Mereo BioPharma Group PLC ADR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$2.66 Million
USD
Capital Expenditures
$0.00
USD
Mereo BioPharma Group PLC ADR Cash Flow Reinvestment Rate by Year (None–None)
Mereo BioPharma Group PLC ADR cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Mereo BioPharma Group PLC ADR. For the full cash flow conversion analysis, see MREO cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow